Concord Drugs Ltd. Live Share Price Today, Share Analysis and Chart

Name: Concord Drugs Ltd.: Is Infosys Ltd. worth buying?
Item: Concord Drugs Ltd.
Rating: 2.633166625
Author: Trendlyne DVM scores

Turnaround Potential

about

56.00 0.00 (0.00%)

6,346

BSE Volume

BSE 30 Jul, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

50.0 / 100

Mid Valuation

46.3 / 100

Technically Moderately Bullish

64.3 / 100

Concord Drugs Live Price Chart

Loading Fundamental data..

Loading data..

12 Votes:

Buy 66.67%

Sell 25.0%

Hold 8.33%